Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Similar Posts
How to trade Costco ahead of next week’s earnings
The ‘Options Action’ traders talk Costco strategy ahead of earnings next week
Housing demand is still outpacing supply, says Evercore ISI’s Kim
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Homebuilders have outperformed, and Evercore ISI homebuilder analyst Stephen King joins ‘The Exchange’ to explain why. 05:41 Fri, May 27 20221:48 PM EDT
American Century’s Rich Weiss still bearish on the market, says it’s difficult to see strong upside
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Closing Bell Rich Weiss, American Century Investments CIO, joins ‘Closing Bell’ to offer his bearish take on the market. 05:23 Wed, Jan 10 20244:54 PM EST
Watch the full discussion on Disney with RBC’s Kutgun Maral and Cowen’s Doug Cruetz
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Kutgun Maral of RBC Capital Markets and Doug Creutz of Cowen join ‘The Exchange’ to discuss streaming stocks like Netflix, Paramount Global and Disney. 07:44 Mon, Jul 18 20221:58 PM EDT
CNBC Make It launches new course to help job seekers ace their interviews
© 2024 CNBC LLC. All Rights Reserved. A Division of NBCUniversal Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis. Market Data Terms of Use and Disclaimers Data also provided by
Washington’s heart ‘really isn’t in it’ with Russia sanctions: Director
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Samuel Greene, director of the Russia Institute and reader of Russian politics at King’s College London, speaks to CNBC about new U.S. sanctions on Nord Stream 2. 01:21 Tue, Dec 24 20196:09 AM EST
